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Immunological memory to pathogens is associated
with clonal expansion and heightened responsive-
ness of antigen-specific T cells. Recent work
emphasizes that, for efficient protective immunity,
qualitative changes in T memory cells are vitally
important.
Exposure to infectious microorganisms generally
leads to a powerful immune response by specific T
and B cells [1,2]. Contact with the pathogen in the
lymph nodes and spleen causes specifically reactive
T and B cells to proliferate extensively and differenti-
ate into effector cells. These cells then home to the
sites of infection and, via a combination of cellular and
humoral (antibody-mediated) immunity, induce rapid
destruction of the pathogen. Being now redundant,
most effector T and B cells are destroyed. However,
some of these cells survive and differentiate into long-
lived memory cells (Figure 1).
Immunological memory is often lifelong and results
in a heightened response to the pathogen upon re-
infection [3–6]. Since memory at the T cell level is
associated with a marked increase in the frequency of
antigen-specific lymphocytes, the simplest explana-
tion for the efficiency of secondary (memory) immune
responses is that there are more reactive cells avail-
able to attack the pathogen than in the primary
response. But is an increase in precursor frequency
alone sufficient to account for memory? According to
a paper published recently in Science by Lauvau et al.
[7], the answer seems to be no. In this paper the
authors found that priming mice with either live or
heat-killed bacteria led to intense proliferation of
antigen-specific T cells followed by survival of a pro-
portion of these cells as memory cells. Surprisingly,
when the mice were later injected with live bacteria,
protective immunity to the pathogen was seen only
after priming with live bacteria. Priming with killed
bacteria was conspicuously ineffective.
To study the requirements for induced protective
immunity, Lauvau et al. [7] examined memory in mice
injected intravenously with Listeria monocytogenes, 
a Gram-positive facultative intracellular bacterium
(Table 1); immunity to this bacterium is known to be
controlled largely by CD8+ T cells. To follow the
response of antigen-specific CD8+ cells to the bacte-
rial antigens, the authors utilized the finding that CD8+
cells react to antigenic peptides bound to class I
major histocompatibility complex (MHC) molecules
and that peptide-specific CD8+ cells can be detected
via binding of soluble MHC class I tetramers plus spe-
cific peptide [6].
As expected, priming mice with live bacteria led 
to marked clonal expansion of specific CD8+ cells in
the primary response and even greater expansion in
the secondary response. Based on T cell binding of
three different peptide–tetramer complexes, the pre-
cursor frequency of CD8+ cells for the bacterial anti-
gens rose from undetectable levels before priming to
2–3% of CD8+ cells at the height of the primary
response (day 7) and then to about 25% during the
secondary response (day 5). Testing the mice 21 days
after initial injection of live bacteria showed strong
protective immunity. Thus, when the mice received a
second intravenous injection of live bacteria, counts of
viable bacteria in the spleen measured 3 days later
were far lower than were found at this time in the
primary response.
These results refer to priming with live bacteria.
When mice were primed with heat-killed bacteria,
clonal expansion and persistence of specific CD8+
cells was as high as for priming with live bacteria.
Thus, when mice were primed with killed bacteria and
then challenged with live bacteria 21 days later, 27%
of CD8+ cells in the spleen were antigen-specific on
day 5 after challenge (compared with 24% for mice
primed – and challenged – with live virus). Despite this
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Figure 1. A scheme for differentiation of naive CD8+ T cells
into memory cells.
During the primary response, naive T cells recognize MHC
class  I–peptide complexes on professional antigen-presenting
cells (dendritic cells) in spleen and lymph nodes and undergo
conspicuous clonal expansion followed by differentiation into
effector cells. After destroying the pathogen, most effector cells
are eliminated, but some of these cells (about 10%) survive to
form long-lived memory cells. Effector memory cells persist in
an activated state and are poised to give very rapid responses
to pathogens upon re-infection. Central memory cells are
resting cells and need to be reactivated before expressing
effector function.
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extremely high proportion of antigen-specific cells,
however, there was no protective immunity: on day 3
after challenge with live bacteria, counts of live bacte-
ria in the spleen were very high, in fact as high as in
primary infection of naive mice.
Since immune responses to infectious agents
involve CD4+ T cells as well as CD8+ cells [1,2], the
lack of immunity in mice primed with killed bacteria
could have reflected a failure to stimulate CD4+ T
cells, the T cell subset that leads to humoral immunity
via stimulation of antigen production by B cells. In the
model studied, however, generation of protective
immunity seemed to be controlled only by CD8+ and
not CD4+ cells. Thus, protective immunity was abol-
ished in mice lacking CD8+ cells but retained in mice
lacking CD4+ cells.
In light of this finding, the authors were faced with a
paradox: when challenged with live bacteria after
priming with killed bacteria, immunity in the spleen was
undetectable even though the spleen contained very
large numbers of specific CD8+ cells. The authors’
explanation for this puzzle is that the specific CD8+
cells failed to express effector function. In support of
this idea, adoptive transfer studies with T cell receptor
transgenic mice specific for one of the bacterial pep-
tides showed that differentiation of CD8+ cells into
cytotoxic T lymphocytes and interferon-γ-producing
cells was conspicuous in hosts primed with live bacte-
ria but almost undetectable in hosts given killed bac-
teria. With the latter, the failure of the transgenic CD8+
cells to differentiate into effector cells correlated with
a small (twofold) reduction in clonal expansion and
impaired downregulation of a lymph node homing
receptor, CD62L. To explain these findings, the authors
suggested that live and killed bacteria are phagocy-
tosed by different antigen-presenting cells, namely by
dendritic cells (‘professional’ antigen-presenting cells)
for live bacteria and macrophages for killed bacteria.
The assumption here is that both types of antigen-pre-
senting cell elicit clonal expansion of CD8+ cells but
only dendritic cells promote differentiation into effec-
tor cells. This interesting idea has yet to be proved.
At face value, these data would seem to provide
strong support for the authors’ conclusion that the
lack of protective immunity after priming with killed
bacteria reflected a failure of memory CD8+ cells to
differentiate into effector cells. However, in the T cell
receptor transgenic model, effector function was
studied only in the primary and not the secondary
response. This is an important omission because the
live bacteria used in the secondary response were
presumably highly immunogenic; here, one would
expect presentation of antigen by professional
antigen-presenting cells to not only induce extensive
proliferation of memory cells but also drive these cells
to differentiate into effector cells. The only direct evi-
dence presented in the paper on this issue, however,
is that bacterial counts measured in the spleen on day
3 were not reduced. This is good evidence for a lack
of protective immunity, but it does not prove that the
memory cells failed to form effector cells. Perhaps
effector cells were formed, but more slowly than in
mice primed with live bacteria (see Table 1 legend)?
In considering this possibility, it is important to bear
in mind that there are two broad subsets of memory 
T cells, termed effector and central memory cells [8].
Effector memory cells lack CCR7 and CD62L lymph
node homing receptors and are scattered throughout
the body. These cells are maintained in an overtly acti-
vated state and thus display very rapid responses
upon secondary contact with antigen. Because of their
activated status, some workers view effector memory
cells as the ‘real’ memory cells controlling protective
immunity [4]. Unlike effector memory cells, central
memory cells are relatively quiescent and resemble
naïve T cells in expressing CCR7 and CD62L recep-
tors. Being resting cells, central memory cells need to
be reactivated, probably by professional antigen-pre-
senting cells, in order to express effector function.
Therefore, in secondary infection, the response of
central memory cells is delayed relative to effector
memory cells. Some workers maintain that this delay
is crucial and makes central memory cells much less
useful than effector memory cells for protective immu-
nity [4]. Others disagree, arguing that the delay in the
response of central memory cells is quite short and
that, being numerous, these cells are highly important
for protective immunity [3].
In the experiments of Lauvau et al. [7], the memory
CD8+ cells found in mice primed with killed bacteria
were CD62L+ and thus had features of central memory
cells. Hence, challenging the primed mice with live
bacteria may have induced strong differentiation of
the memory cells into effector cells, but with delayed
kinetics (relative to mice primed with live bacteria). If
so, bacterial counts in the spleen may have declined
precipitously, but only in the later stages of the
response. Since bacterial counts were measured only
on day 3, this possibility was not ruled out.
But suppose the authors tested this idea and found
no evidence of protective immunity and no induction
of cytotoxic T lymphocytes? Such a finding would 
be most intriguing and suggest that the memory CD8+
cells generated after priming with killed bacteria 
were functionally anergic: the memory cells prolifer-
ated extensively when challenged with live bacteria,
but, because of aberrant priming, were unable to 
Table 1. A description of the model used by Lauvau et al. [7] (see
text).
Primary response Secondary response 
after challenge with
live bacteria
Bacteria used Clonal Effector Clonal Elimination
for priming expansion function expansion of bacteria
Live ++++ ++++ ++++ ++++
Killed ++++ – ++++ –
It should be noted that, in the secondary response, precursor fre-
quencies of antigen-specific CD8+ cells were measured only on day
5; data on precursor frequencies just prior to challenge with live virus
were not presented. Hence, prior to challenge, total numbers of spe-
cific memory cells could have been lower in the group primed with
killed bacteria, thus delaying the onset of effector cell generation.
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differentiate into effector cells. A precedent for this
idea comes from the finding that memory CD8+ cells
in patients with AIDS [9] and mice chronically infected
with lymphocytic choriomeningitis virus [10] display
only very limited cytotoxic T lymphocyte activity.
However, in these chronic infections, anergy of CD8+
cells may be largely a reflection of continuous T cell
stimulation. By contrast, antigen levels in mice primed
with killed bacteria probably decline abruptly within a
few days.
Whatever the explanation, the apparent incompe-
tence of memory CD8+ cells generated in response to
killed bacteria has important implications for vaccine
design. With some notable exceptions, for example
the Salk vaccine for poliomyelitis, vaccination with
killed microorganisms often affords poor protection
and may rely largely on humoral immunity via antibody
production [11]. Since effective (live) vaccines gener-
ally elicit powerful primary responses of T cells, the
limited cellular immunity induced by killed microor-
ganisms is usually attributed to weak priming of
T cells. This assumption is clearly questioned by the
finding of Lauvau et al. [7] that a killed vaccine can
induce intense T cell proliferation but provide poor
protection. Defining precisely why the memory cells in
this situation are incompetent could be vital for
improving vaccine design.
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